The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults. Although aerosolized ribavirin was licensed for RSV treatment on the basis of data demonstrating a reduced need for supplemental oxygen, ribavirin use...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infectious diseases and therapy 2021-03, Vol.10 (Suppl 1), p.47-60
Hauptverfasser:	Domachowske, Joseph B., Anderson, Evan J., Goldstein, Mitchell
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Biological products Biotechnology industry Care and treatment Developmental stages Disease prevention Infants Infection Infectious Diseases Internal Medicine Medical colleges Medicine Medicine & Public Health Monoclonal antibodies Palivizumab Pediatrics Pharmaceutical industry Prevention Respiratory syncytial virus Respiratory tract Respiratory tract diseases Review Virus diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!